MX2009010428A - Agente profilactico para insuficiencia renal. - Google Patents

Agente profilactico para insuficiencia renal.

Info

Publication number
MX2009010428A
MX2009010428A MX2009010428A MX2009010428A MX2009010428A MX 2009010428 A MX2009010428 A MX 2009010428A MX 2009010428 A MX2009010428 A MX 2009010428A MX 2009010428 A MX2009010428 A MX 2009010428A MX 2009010428 A MX2009010428 A MX 2009010428A
Authority
MX
Mexico
Prior art keywords
renal
renal failure
prophylactic agent
preventing
arteriosclerosis
Prior art date
Application number
MX2009010428A
Other languages
English (en)
Inventor
Toshiaki Takano
Tatsuhiko Hirota
Kohji Ohki
Teppei Nakamura
Original Assignee
Calpis Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Calpis Co Ltd filed Critical Calpis Co Ltd
Publication of MX2009010428A publication Critical patent/MX2009010428A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Se expone un agente capaz de prevenir una enfermedad glomerular renal o una arteriosclerosis renal; también se expone un agente profiláctico para la insuficiencia renal o un alimento funcional que se espera que tenga actividad profiláctica en la insuficiencia renal, el cual comprende el agente capaz de prevenir una enfermedad glomerular renal o una arteriosclerosis renal; el agente capaz de prevenir una enfermedad glomerular renal o una arteriosclerosis renal comprende Xaa-Pro-Pro como ingrediente activo.
MX2009010428A 2007-03-27 2008-03-19 Agente profilactico para insuficiencia renal. MX2009010428A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007081638 2007-03-27
PCT/JP2008/055073 WO2008123096A1 (ja) 2007-03-27 2008-03-19 腎不全予防剤

Publications (1)

Publication Number Publication Date
MX2009010428A true MX2009010428A (es) 2009-12-01

Family

ID=39830596

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2009010428A MX2009010428A (es) 2007-03-27 2008-03-19 Agente profilactico para insuficiencia renal.
MX2009010427A MX2009010427A (es) 2007-03-27 2008-03-19 Agente profilactico para la insuficiencia cardiaca.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2009010427A MX2009010427A (es) 2007-03-27 2008-03-19 Agente profilactico para la insuficiencia cardiaca.

Country Status (10)

Country Link
US (4) US20100022747A1 (es)
EP (2) EP2138184B1 (es)
JP (2) JP5292632B2 (es)
KR (2) KR20090130303A (es)
CN (2) CN101678071A (es)
BR (1) BRPI0809319A2 (es)
CA (2) CA2681551C (es)
EA (1) EA016808B1 (es)
MX (2) MX2009010428A (es)
WO (2) WO2008123096A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2009010428A (es) * 2007-03-27 2009-12-01 Calpis Co Ltd Agente profilactico para insuficiencia renal.
JP5686680B2 (ja) * 2011-06-24 2015-03-18 カルピス株式会社 乳酸菌発酵によるカゼイン由来ペプチドの製造方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2782142B2 (ja) * 1992-07-23 1998-07-30 カルピス株式会社 アンジオテンシン変換酵素阻害剤及びその製造法
JP3028411B2 (ja) * 1997-09-26 2000-04-04 カルピス株式会社 トリペプチド高生産性ラクトバチルス・ヘルベチカス乳酸菌
FI113741B (fi) * 1999-11-01 2004-06-15 Valio Oy Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi
ZA200507880B (en) 2003-05-05 2006-12-27 Unilever Plc Hydrolysed casein product comprising tripeptides IPP and/or VPP
UA89616C2 (ru) * 2003-08-01 2010-02-25 Калпис Ко., Лтд. Гидролизат казеина, способ его получения и применения
EA011865B1 (ru) * 2004-07-12 2009-06-30 ДСМ Ай Пи ЭССЕТС Б.В. Протеиновые гидролизаты, снижающие давление крови
ES2384637T3 (es) * 2004-10-08 2012-07-10 Novartis Ag Uso de inhibidores de la renina para la prevención o el tratamiento de disfunción diastólica o insuficiencia cardiaca diastólica
US20060205642A1 (en) * 2005-03-08 2006-09-14 Vesely David L Oral methods of treatment using proANF peptides
AU2006273395B2 (en) * 2005-07-26 2012-10-04 Calpis Co., Ltd. Process for production of fermented milk and fermented milk beverage/food
JP5096173B2 (ja) * 2006-02-09 2012-12-12 カルピス株式会社 経口摂取用関節リウマチ抑制剤
BRPI0707827A2 (pt) * 2006-02-14 2011-05-10 Calpis Co Ltd vasodilatador
US20090299036A1 (en) * 2006-02-14 2009-12-03 Calpis Co, Ltd Agent for preventing arteriosclerosis, agent for suppressing vascular intimal thickening and agent for improving vascular endothelial function
MX2009010428A (es) * 2007-03-27 2009-12-01 Calpis Co Ltd Agente profilactico para insuficiencia renal.

Also Published As

Publication number Publication date
EP2130546A1 (en) 2009-12-09
CN101641113A (zh) 2010-02-03
US20100022747A1 (en) 2010-01-28
EP2138184A1 (en) 2009-12-30
WO2008123095A1 (ja) 2008-10-16
WO2008123096A1 (ja) 2008-10-16
KR20090127174A (ko) 2009-12-09
EA016808B1 (ru) 2012-07-30
CA2681746A1 (en) 2008-10-16
US20100022748A1 (en) 2010-01-28
US8673854B2 (en) 2014-03-18
MX2009010427A (es) 2009-10-20
BRPI0809319A2 (pt) 2014-09-23
US20120058947A1 (en) 2012-03-08
JPWO2008123096A1 (ja) 2010-07-15
EP2138184A4 (en) 2010-04-07
CN101678071A (zh) 2010-03-24
JP5292633B2 (ja) 2013-09-18
EA200970893A1 (ru) 2010-04-30
CA2681746C (en) 2014-04-29
KR20090130303A (ko) 2009-12-22
EP2138184B1 (en) 2013-09-18
JP5292632B2 (ja) 2013-09-18
EP2130546B1 (en) 2013-02-27
JPWO2008123095A1 (ja) 2010-07-15
US20120077735A1 (en) 2012-03-29
CA2681551A1 (en) 2008-10-16
CA2681551C (en) 2014-06-10
EP2130546A4 (en) 2010-03-31

Similar Documents

Publication Publication Date Title
WO2008114800A3 (en) Solid preparation comprising 2- [ [6- [ (3r) -3-amino-1-piperidinyl] -3, 4-dihydro-3-methyl-2, 4-dioxo-1 (2h) -pyrimidinyl] methyl] -4-fluorobenzonitrile
MX2010005889A (es) Derivados de tiofeno como agonistas de s1p1/edg1.
WO2010128050A3 (en) Dihydroorotate - dehydrogenasee inhibitors as virostatic compounds
MY154909A (en) Novel thiophene derivatives
WO2009041705A3 (en) 5-membered heterocyclic compounds as proton pump inhibitors
BRPI0812027A2 (pt) Composto 1,3 diona bicíclicos herbicidamente ativos.
MY184985A (en) Oligosaccharide mixture and food product comprising this mixture, especially infant formula
WO2009057079A3 (en) Novel pyrimidine derivatives
TN2012000092A1 (en) Therapeutic agent for mood disorders
WO2011012816A3 (fr) Formulation pharmaceutique
WO2009041663A1 (ja) 皮膚疾患の予防及び／または治療剤
TW200942530A (en) Pyridine compounds
WO2011002857A3 (en) 3-cyanoquinoline tablet formulations and uses thereof
WO2009051223A1 (ja) 白内障処置のための医薬組成物
WO2008153129A1 (ja) 尿酸値低下剤
WO2010082689A3 (en) Gip-increase inhibitor
WO2008068299A3 (en) Hydrobromide salt of an anti-hiv compound
MX2007003196A (es) Agente y alimento para evitar/mejorar el trastorno digestivo funcional.
WO2010119102A3 (de) Pharmaceutische zusammensetzung enthaltend protonenpumpenhemmer zur behandlung von dermatologischen autoimmunerkrankungen
WO2009018551A3 (en) Therapeutic compounds
MX2009010428A (es) Agente profilactico para insuficiencia renal.
TN2012000093A1 (en) Therapeutic agent for anxiety disorders
WO2008146883A1 (ja) 睡眠改善剤
WO2009097973A3 (de) Imidazopyridazine als par1-inhibitoren, ihre herstellung und verwendung als arzneimittel
MX2012004087A (es) Sulfonamidas para la prevencion de diabetes.

Legal Events

Date Code Title Description
FG Grant or registration